drugset / Trial / NCT07272629

A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.

NCT07272629

Phase 1 Completed 48 enrolled Sanofi
RandomizedCrossoverDouble-blindTreatment

Summary

This is a Phase 1, multicenter, randomized, double-blind, double-dummy, single dose, placebo- and positive-controlled, 4-sequence, 4-treatment, 4-period crossover study.

Timeline

Start
2025-12-04
Primary completion
2026-05-28
Completion
2026-06-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Balinatunfib Small molecule Oral
Comparator Moxifloxacin Small molecule Oral

Indications

No indication recorded.